---
title: "Compounded Aseptic Medicines"
ocid: "ocds-h6vhtk-04e7a2"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04e7a2"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04e7a2.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04e7a2.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-02-24"
---

# Compounded Aseptic Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-h6vhtk-04e7a2

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04e7a2)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04e7a2.json)

## Summary

The Common Services Agency, also known as NHS National Services Scotland (NSS), has concluded the award stage of a public procurement process titled "Compounded Aseptic Medicines". This procurement, under the industry category of Pharmaceutical Products (CPV code 33600000), pertains to the supply of unlicensed, aseptically compounded, ready-to-use medicines in syringes and infusion bags to NHS Scotland. The framework agreement, spanning twelve months, includes four lots covering various medicines. The procurement process followed a limited method without prior publication of a call for competition due to unforeseen circumstances related to the Covid-19 pandemic, and final contracts were signed on February 24, 2025. Deliveries will cover all entities constituted under the National Health Service (Scotland) Act 1978 and relevant Integrated Joint Boards.

This tender presents significant opportunities for business growth, especially for suppliers in the pharmaceutical sector capable of producing aseptically compounded medicines. It provides substantial financial opportunities, with individual contracts valued at £13,653,346, £1,565,729, £1,064,777, and £5,085,024 respectively. Companies like Baxter Healthcare Ltd, Qualasept Limited t/a Bath ASU, and ITH Pharma Limited are poised to benefit from the framework agreements. The emphasis on ready-to-use medicines in syringes and infusion bags ensures demand continuity, making it an excellent opportunity for businesses specializing in pharmaceutical products to secure long-term supply contracts and establish strong relations with NHS Scotland.

## Notice

This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland.

### Lot Information

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra(r)), (Remicade(r)), (Remsima(r)) Nivolumab Pembrolizumab Pertuzumab The Authority intends to awarded all presentations within this Lot to a single supplier.

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Cyclophosphamide Fluorouracil Irinotecan Methotrexate Rituximab (Mabthera(r)), (Rixathon(r)), (Truxima(r)) The Authority intends to awarded all presentations within this Lot to a single supplier

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Bortezomib Carboplatin Cisplatin Docetaxel Gemcitabine Oxaliplatin Trastuzumab (Herceptin(r)), (Herzuma(r)) Vincristine The Authority intends to awarded all presentations within this Lot to a single supplier.

Compounded Aseptic Medicines - All Other Presentations

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, The molecules included in this Lot are, Bevacizumab Cytarabine Infliximab (Zessly(r)) Insulin Methotrexate Natalizumab Nivolumab Paclitaxel Pemetrexed Tocilizumab Trastuzumab (Kanjinti(r)), (Ontruzant(r)) Trastuzumab Subcutaneous Vedolizumab Each product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework.

### Procurement Information

This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/007093-2025 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 24 Feb 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 24 Feb 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £21,368,876 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 3 |
| Supplier names | BAXTER HEALTHCARE; ITH PHARMA; QUALASEPT LIMITED T/A BATH ASU |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 24 Feb 2025 at 16:38 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/007093-2025

## Notice URLs

- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000790498
- https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=790498
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04e7a2. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04e7a2.json.